Status:
COMPLETED
Chronic Obstructive Pulmonary Disease in Combination With Atherosclerosis (Clinical and Biochemical Study)
Lead Sponsor:
Ryazan State Medical University
Conditions:
Chronic Obstructive Pulmonary Disease
Peripheral Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
one-centered, open, non-randomized, controlled clinical trial will focus on a comprehensive study of the clinical, functional and molecular biochemical characteristics of the natural course of COPD in...
Detailed Description
Risk factors, chronic respiratory symptoms and respiratory function in the natural history of COPD will be monitored. In a group of patients with a comorbid course of COPD and atherosclerosis, systemi...
Eligibility Criteria
Inclusion
- A significant diagnosis of COPD, confirmed by spirometry criteria, typical clinical presentation.
- A significant diagnosis of peripheral atherosclerosis
- The high level of adherence to treatment
- Signed informed agreement
Exclusion
- The presence of other chronic respiratory diseases in the patient, including bronchial asthma
- Known oncological diseases of any localization
- HIV infection and other immunodeficiency conditions
- Inability to understand and comply with the requirements of the research protocol.
Key Trial Info
Start Date :
November 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 19 2023
Estimated Enrollment :
476 Patients enrolled
Trial Details
Trial ID
NCT04474717
Start Date
November 15 2020
End Date
July 19 2023
Last Update
July 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ryazan State Medical University
Ryazan, Please Select, Russia, 390005